Skip to playerSkip to main content
  • 3 years ago
#Q4WithBQ | Suven Life Sciences' revenue contracts and loss widens on an yearly basis. Can company see improved performance in FY24?
In conversation with Chairman & CEO Venkat Jasti. #BQLive

Category

🗞
News
Comments

Recommended